tiprankstipranks
Santhera Pharmaceuticals Holding (SPHDF)
OTHER OTC:SPHDF
Want to see SPHDF full AI Analyst Report?

Compare Santhera Pharmaceuticals Holding (SPHDF) vs. Competitors

40 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Santhera Pharmaceuticals Holding
$22.28
$326.35M
-4.06
43.14%
1 Buy
0 Hold
0 Sell
Moderate Buy
Molecular Partners AG
CHF3.41
CHF130.81M
-2.50
-3.86%
1 Buy
0 Hold
0 Sell
Moderate Buy
Basilea Pharmaceutica
CHF52.60
CHF669.55M
6.84
22.61%
1 Buy
0 Hold
0 Sell
Moderate Buy
Idorsia Ltd
CHF3.71
CHF991.05M
-4.80
178.32%
2 Buy
0 Hold
0 Sell
Moderate Buy
Newron Pharmaceuticals SpA
CHF16.44
CHF287.54M
-9.69
74.06%
1 Buy
0 Hold
0 Sell
Moderate Buy
Xlife Sciences Ltd.
CHF22.90
CHF121.70M
3.92
2.93%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
SPHDF
Santhera Pharmaceuticals Holding
23.73
8.03
51.11%
CH:MOLN
Molecular Partners AG
3.24
-0.20
-5.81%
CH:BSLN
Basilea Pharmaceutica
54.50
10.10
22.75%
CH:IDIA
Idorsia Ltd
3.90
2.62
204.37%
CH:NWRN
Newron Pharmaceuticals SpA
13.82
5.58
67.72%
CH:XLS
Xlife Sciences Ltd.
21.10
0.60
2.93%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts